The medical management of inflammatory bowel disease, which includes Crohn disease and ulcerative colitis, has evolved significantly with the development of targeted therapies. Because IBD is caused by an overactive immune system attacking the digestive tract, the primary goal of medication is to reduce inflammation, allow the gut lining to heal, and maintain long term remission. In the United Kingdom, treatment pathways are structured to provide the most appropriate medication based on the severity of the disease, its location, and the specific type of IBD. Modern clinical approaches often aim for deep mucosal healing to prevent structural damage to the bowel and reduce the long term risk of surgery.
What we will discuss in this article
- The role of aminosalicylates in managing mild to moderate inflammation
- How corticosteroids are used to quickly control acute flare ups
- The use of immunosuppressants to maintain long term stability
- Advanced biologic therapies and biosimilars for moderate to severe disease
- Newer small molecule treatments that target specific inflammatory pathways
- The importance of personalised treatment plans and regular monitoring
- Emergency guidance for identifying severe medication side effects or flares
Amino salicylates
Amino salicylates, often called 5 ASAs, are frequently the first line of treatment for patients with mild to moderate ulcerative colitis and, less commonly, some forms of Crohn disease.
These medications work by directly reducing inflammation in the lining of the gut. They are available in various forms, including oral tablets, granules, and topical preparations like suppositories or enemas. Topical treatments are particularly effective for proctitis because they deliver the medicine directly to the site of inflammation. Common examples used in clinical practice include mesalazine, sulfasalazine, and balsalazide. For many patients with ulcerative colitis, staying on a 5 ASA indefinitely is the key to preventing future flare ups and reducing the risk of colon cancer.
Corticosteroids
Corticosteroids are powerful anti inflammatory drugs used to bring active inflammation under control quickly.
Acute flare management
Steroids like prednisolone or hydrocortisone are highly effective at inducing remission during a flare up. However, they are not suitable for long term use because of their significant side effects, which can include weight gain, mood changes, increased infection risk, and bone thinning. Clinical guidelines emphasise that steroids should be tapered down slowly and should not be used as a maintenance therapy. If a patient requires repeated courses of steroids, it is usually a signal that their maintenance treatment needs to be escalated to a more potent medication.
Immunosuppressants
When 5 ASAs are not enough to keep the disease in remission, doctors may prescribe immunosuppressants, also known as immunomodulators.
These drugs work by dampening the overall activity of the immune system. The most common examples are azathioprine and mercaptopurine. Another option is methotrexate, which is more frequently used for Crohn disease. Because these medications take several months to reach full effectiveness, they are often started alongside a course of steroids. Patients taking these drugs require regular blood tests to monitor their liver function and white blood cell counts, as they can occasionally affect the bone marrow or liver.
Biologic therapies and biosimilars
Biologics represent a significant advancement in the treatment of moderate to severe IBD. Unlike traditional drugs, these are large, complex proteins made from living cells.
Targeted treatment
Biologics work by blocking specific proteins in the immune system that cause inflammation, such as tumour necrosis factor. Common biologics include infliximab, adalimumab, vedolisumab, and ustekinumab. In the UK, many patients now use biosimilars, which are highly similar and equally effective versions of the original biologic drugs. These medications are usually administered via an intravenous infusion in a hospital setting or by a self administered injection at home. They have been shown to be very effective at achieving mucosal healing and reducing the need for surgery.
Medication category summary
| Medication Class | Primary Purpose | Common Examples |
| Aminosalicylates | Maintain remission (UC) | Mesalazine, Sulfasalazine |
| Corticosteroids | Induce remission quickly | Prednisolone, Hydrocortisone |
| Immunosuppressants | Long term maintenance | Azathioprine, Methotrexate |
| Biologics | Target specific proteins | Infliximab, Adalimumab |
| Small Molecules | Block cell signalling | Tofacitinib, Filgotinib |
Emergency guidance
While IBD medications are vital for health, certain situations involving active disease or severe drug reactions require immediate medical attention.
If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Seek urgent medical help if you notice:
- Signs of a severe allergic reaction to a biologic infusion such as difficulty breathing or swelling of the face
- A high fever combined with severe abdominal pain and a rigid swollen tummy
- Symptoms of a severe infection while on immunosuppressants such as shaking chills or a persistent cough
- Heavy or non stop rectal bleeding that makes you feel faint or diszy
- Signs of liver issues while on azathioprine such as yellowing of the skin or eyes
To summarise
The medications used to treat IBD range from mild anti inflammatories like 5 ASAs to advanced biologic therapies that target specific immune pathways. Corticosteroids remain the primary tool for stopping acute flares, while immunosuppressants and biologics are used to maintain stability over the long term. A personalised clinical approach is essential, as the choice of drug depends on the type of disease and how much of the gut is affected. By consistently taking maintenance medication and attending regular monitoring appointments, most people with IBD can control their inflammation and live a full active life.
Why am I on two different medications for my IBD?
It is common to use combination therapy, such as a biologic and an immunosuppressant. This can make the treatment more effective and prevent your body from developing antibodies against the biologic drug.
Do I have to take these medications during pregnancy?
Many IBD medications are safe to continue during pregnancy, and keeping your disease in remission is the best thing for both you and the baby. Always discuss your pregnancy plans with your specialist.
Are biologics safe for long term use?
Yes, biologics are monitored closely and many people have been using them for years with great success. Your specialist will regularly assess if the treatment is still working and if it is safe for you.
Can I switch from an infusion to an injection?
For some biologics, both versions are available. You should speak with your gastroenterology team to see if switching to a home injection is a suitable option for your specific treatment.
What is a steroid taper?
A taper is a gradual reduction of your steroid dose over several weeks. This allows your body to slowly restart its own natural production of hormones that were suppressed by the medication.
Will I be more prone to infections?
Immunosuppressants and biologics can slightly increase your risk of infections. It is important to stay up to date with recommended vaccinations and seek medical advice if you develop signs of an illness.
Can I drink alcohol with these medications?
Alcohol can irritate the gut and may interact with certain immunosuppressants like methotrexate. It is usually best to limit alcohol and discuss specifics with your doctor.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and postgraduate certifications including Basic Life Support, Advanced Cardiac Life Support, and the UK Medical Licensing Assessment. He has hands on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient focused health content and teaching clinical skills to junior doctors.
